Literature DB >> 23153049

Comparing the effects of three different intravitreal injection techniques on vitreous reflux and intraocular pressure.

Abdullah Özkaya1, Zeynep Alkin, Uğur Celik, Kemal Yüksel, Engin Bilge Ozgurhan, Alper Ağca, Ahmet Taylan Yazici, Ahmet Demirok.   

Abstract

PURPOSE: To compare the effects of straight, oblique, and double-plane tunnel scleral intravitreal injection techniques, on short-term intraocular pressure (IOP) changes, occurrence of vitreous reflux (VR), and/or other complications.
METHODS: A total of 105 patients were included in this prospective study. Patients were assigned randomly to one of the straight injection group (SI; n=35), oblique injection group (OI; n=35), or double-plane tunnel injection group (DPTI; n=35). The occurrence of VR and preinjection and postinjection IOP at 2 and 6 h were compared between groups, and complications were assessed.
RESULTS: The mean patient age was 71.1±6.6 years (range 58 to 86 years; 50 women and 55 men). In the SI, OI, and DPTI groups, VR occurred in 18 (51.4%), 12 (34.3%), and 6 patients (17.1%), respectively. Mean preinjection IOPs were 15.4, 14.8, and 15.6 mmHg, and changed to 17.3, 18.0, and 20.0 mmHg at the second hour, and 15.7, 16.2, and 16.1 mmHg at the sixth hour, respectively. No significant differences among the groups were found in terms of complications such as transient mild uveitis or subconjunctival hemorrhage.
CONCLUSION: Double-plane tunnel injection prevents VR from the injection site and has no additional complications than other techniques.

Entities:  

Mesh:

Year:  2012        PMID: 23153049     DOI: 10.1089/jop.2012.0144

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  8 in total

Review 1.  Intravitreal, Subretinal, and Suprachoroidal Injections: Evolution of Microneedles for Drug Delivery.

Authors:  Rachel R Hartman; Uday B Kompella
Journal:  J Ocul Pharmacol Ther       Date:  2017-12-05       Impact factor: 2.671

2.  Reflux, Intraocular Pressure Variation and Pain Following Intravitreal Ranibizumab Injections Using 30-Gauge or 32-Gauge Needles for Patients With Retinal Pathologies: A Randomized Clinical Trial.

Authors:  Saeed T Alshahrani; Uriel Rubin; Vasudha Gupta; Tom Gonder; Sanjay Sharma
Journal:  Cureus       Date:  2021-04-06

3.  Novel Needle for Intravitreal Drug Delivery: Comparative Study of Needle Tip Aspirates, Injection Stream and Penetration Forces.

Authors:  Lyubomyr M Lytvynchuk; Goran Petrovski; Adien Dam; Joep Hiemstra; Tobias Wimmer; Iryna Savytska; Susanne Binder; Knut Stieger
Journal:  Clin Ophthalmol       Date:  2021-02-19

Review 4.  Endophthalmitis following intravitreal anti-vascular endothelial growth factor (VEGF) injection: a comprehensive review.

Authors:  Rohan Merani; Alex P Hunyor
Journal:  Int J Retina Vitreous       Date:  2015-07-21

5.  Comparison between two intravitreal injection techniques with respect to fluid reflux, intraocular pressure, and therapeutic effect.

Authors:  Shashi Tanwar; Arun Kumar Sharma; Rajat Mohan Srivastava; Vishal Katiyar; Siddharth Agrawal; Sanjiv Kumar Gupta
Journal:  Oman J Ophthalmol       Date:  2021-02-27

Review 6.  Extraocular, periocular, and intraocular routes for sustained drug delivery for glaucoma.

Authors:  Uday B Kompella; Rachel R Hartman; Madhoosudan A Patil
Journal:  Prog Retin Eye Res       Date:  2020-09-04       Impact factor: 21.198

7.  Comparison of Guided and Unguided Ocriplasmin Injection for the Treatment of Vitreomacular Traction: A Preliminary Study.

Authors:  Rodolfo Mastropasqua; Luca Di Antonio; Vincenzo Ciciarelli; Agbeanda Aharrh-Gnama; Marco Rispoli; Paolo Carpineto
Journal:  J Ophthalmol       Date:  2016-03-15       Impact factor: 1.909

8.  The effects of intravitreal injections on intraocular pressure and retinal nerve fiber layer: a systematic review and meta-analysis.

Authors:  Victor A de Vries; Fabiana L Bassil; Wishal D Ramdas
Journal:  Sci Rep       Date:  2020-08-06       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.